Nu Skin Enterprises Reports First Quarter Financial Results; Company Reports Constant Currency Revenue Gains of 6 Percent

Apr 26, 2001, 01:00 ET from Nu Skin Enterprises, Inc.

    PROVO, Utah, April 26 /PRNewswire/ -- Nu Skin Enterprises, Inc.
 (NYSE:   NUS) today reported financial results for the first quarter ended March
 31, 2001.
 
                               Financial Results
     "Global revenue was up 6 percent year-over-year in constant currency, and
 we were pleased to realize overall results that were within our expectations,"
 said Steven J. Lund, president and chief executive officer, commenting on
 first quarter results.  "Weak foreign currencies negatively impacted our
 reported revenue, however, offsetting significant product sales from a global
 distributor convention held in February."
     For the first quarter, the company's reported revenue was $210.3 million
 compared to $213.6 million for the first quarter of 2000.  Net income was
 $12.6 million and earnings per share were $0.15 compared to $14.9 million and
 $0.17 per share for the same prior-year period.
 
                                Regional Results
     North Asia.  Revenue in the North Asia region was up 2 percent year-over-
 year on a constant currency basis.  However, due to negative foreign currency
 impact, revenue in the region declined 7 percent in U.S. dollars.  In Japan,
 local currency revenue remained level with the prior year, a positive showing
 given a convention was held in Japan during the prior year period.  In South
 Korea, revenue growth continued, up nearly 60 percent in local currency.
     Southeast Asia.  In constant currency, revenue in the Southeast Asia
 region rose 4 percent over a year ago, or 1 percent on a reported U.S. dollar
 basis, largely from revenue in Singapore, where operating results continue to
 exceed expectations.  The company's success in Singapore offset a 16 percent
 year-over-year decline in Taiwan in local currency.  Taiwan continues to
 suffer from distributor focus on stronger markets in the region and from a
 competitive local business environment.
     North America.  Revenue in the North America region was up 13 percent over
 the first quarter of 2000, with all three divisions benefiting from the
 successful February convention, which generated $5 million in incremental
 revenue.  Revenue in North America was also positively impacted by
 $5.7 million from a new business development venture that is included in Big
 Planet's results.  Without the impact of this additional revenue and
 incremental convention sales, revenue in North America would have been down
 13 percent year-over-year, but essentially level on a sequential basis.
     Other Markets.  All other markets experienced year-over-year gains, in
 local currency, up a collective 35 percent from first quarter 2000 results.
 European markets showed an increase of 52 percent in local currency,
 42 percent in U.S. dollars.  The Scandinavian countries, in particular, showed
 increases in both distributor leadership and revenue.
 
                               Divisional Reports
     Nu Skin Division.  Revenue from the Nu Skin division during the first
 quarter was down 2 percent year-over-year in constant currency terms, and down
 10 percent on a reported U.S. dollar basis to $100.1 million.  Two of the
 products introduced at the convention, the Galvanic Spa System(TM) and Tru
 Face(TM) Line Corrector, quickly became two of the division's top selling
 products in the U.S.  These and other new products will be rolled out globally
 during 2001.
     Pharmanex.  First quarter revenue from Pharmanex was up 12 percent in
 constant currency terms, and up 3 percent in U.S. dollars to $93.4 million.
 Pharmanex's personalized distributor web site program continues to drive
 growth in Japan, with some 26,000 sites now in operation.  In addition, the
 distributor automatic ordering program, launched in 2000 in Japan, now
 accounts for 30 percent of global division revenue, providing a more stable,
 recurring revenue stream.  During the February convention, Pharmanex
 introduced both Body Design(TM), a weight management system, as well as its
 reformulated anti-aging LifePak(TM) line of products.
     In early April, a U.S. Federal judge ruled that Cholestin, Pharmanex's
 primary cholesterol product, could no longer be marketed in the U.S. as a
 dietary supplement.  A more comprehensive cardiovascular product, Cardio
 Formula(TM), which was introduced at convention, is now being sold in the U.S.
 International sales of Cholestin are not expected to be affected by the U.S.
 ruling.
 
     Big Planet.  Big Planet's core global revenue was $11.1 million for the
 quarter, up 18 percent from a year ago, including $2.6 million of revenue from
 international markets.  With the inclusion of $5.7 million of new business
 development revenue in the quarter, which previously was not included in Big
 Planet's results, global revenue was $16.8 million.  Big Planet's U.S. revenue
 declined 10 percent from the previous year, due largely to the company's
 decision to discontinue unprofitable programs and to focus on improving
 operating margins.  For example, during the quarter, Big Planet entered into a
 relationship with Planet Electric to distribute products incorporating
 innovative battery technology.  The cash investment in Big Planet was
 $4.5 million in the quarter, and is expected to be less than $3 million in the
 second quarter.
 
                            Operational Performance
     Gross margins were lower in the first quarter, due primarily to the impact
 of weaker foreign currencies and from an increase in lower margin Big Planet
 revenue.  Selling, general and administrative expenses were lower than
 projected, due to tightened cost controls, as well as a weakened Japanese Yen.
 SG&A expenses for the quarter also included the cost of the global convention.
 With a renewed focus on cost-containment, as well as the projected impact of a
 stronger dollar, quarterly SG&A expenses are expected to be lower throughout
 the remainder of 2001.  While operating income was negatively affected by
 foreign currencies, significant hedging gains as a result of the stronger U.S.
 dollar helped to offset the currency impact.  As a result, net income and
 earnings per share were in line with the company's expectations for the
 quarter.
 
                                    Outlook
     "Overall," Mr. Lund noted, "we are optimistic about the outlook for local
 currency revenue growth in most of our international markets.  But weak
 foreign currencies, particularly the Japanese Yen, will impact revenue and
 earnings per share for the year.  At a forecasted exchange rate of 125 Yen to
 the U.S. dollar, the outlook for revenue in 2001 is between $840 and
 $870 million, with earnings per share of $0.58 to $0.62.  We also expect
 reported revenue and earnings per share in the second quarter to be relatively
 level with first quarter results."
     Mr. Lund emphasized that the company's priorities during 2001 will be to
 accomplish five major goals, which are:
 
     --  to grow the U.S. business;
     --  to refine the company's divisional strategy;
     --  to increase distributor productivity through Internet and automatic
         delivery type programs;
     --  to further tighten cost controls consistent with projected revenue
         levels; and,
     --  to globalize new product offerings.
 
     "These priorities reflect our commitment to constantly adapt to meet the
 changing business environment in which we operate.  While always supporting
 the need for stability in our business, we will staunchly adhere to the tenet
 that our business success comes from adjusting, as necessary, both our goals
 and the tactics necessary to reach them," he concluded.
 
     The Company
     Nu Skin Enterprises, Inc. is one of the largest direct selling companies
 in the world.  The company's products are sold in more than 30 countries
 throughout the Americas, Europe and the Asia Pacific region.  Nu Skin
 Enterprises is traded on the New York Stock Exchange under the symbol "NUS."
     Nu Skin Enterprises offers three distinct business opportunities
 specializing in consumer products and services sold through direct sales.  Nu
 Skin markets premium quality face, body and hair care products.  Pharmanex is
 a science-based developer and marketer of nutritional supplements.  Big Planet
 concentrates on the marketing and distribution of technology-based products
 and services.
     Nu Skin Enterprises news releases are available online at
 www.nuskinenterprises.com or through the Company News On-Call fax service. For
 a menu of Nu Skin Enterprises news or to retrieve a specific release, call
 800-758-5804, extension 119638.
 
     Please note:  This press release contains forward-looking statements
 within the meaning of Section 21E of the Securities Exchange Act of 1934 that
 represent the company's current expectations and beliefs, including, among
 other things: (i) expectations that the cash investment in Big Planet will be
 less than $3 million in the 2nd quarter, (ii) the belief that selling, general
 and administrative expenses will be lower for the remainder of the year, (iii)
 the forecast that revenue for 2001 will be between $840 and $870 million and
 earnings per share will be $0.58 to $0.62, and (iv) the belief that revenue
 and earnings for the second quarter will be relatively level with the first
 quarter.  The company wishes to caution and advise readers that these
 statements are based on assumptions which may not materialize, including
 assumptions that the Japanese Yen will remain at current levels and that the
 company's initiatives in Japan will continue to have a positive impact on
 revenue.  The forward-looking statements and related assumptions involve risks
 and uncertainties that could cause actual results and outcomes to differ
 materially from any forward-looking statements or views expressed herein.
 These risks and uncertainties include, but are not limited to: (a) adverse
 changes in currency exchange rates, particularly the Japanese Yen; (b)
 continued or increased economic problems in the company's markets,
 particularly the United States and Japan, that have negatively impacted
 consumer spending in those markets; (c) uncertainty concerning the long-term
 effects of recent initiatives and the risk that the recent stabilization of
 operations in Japan may not be sustained or be indicative of future operating
 results; (d) uncertainties regarding the degree to which the new products
 launched at convention will gain market acceptance and generate interest among
 distributors and consumers in global markets; (e) any inability of the company
 to successfully develop and implement strategic initiatives that will generate
 new and sustained growth in Taiwan and the United States; (f) continued
 competitive pressures in the company's markets; and, (g) regulatory risks
 associated with the company's business and product offerings, including
 possible restrictions on or challenges to the company's marketing practices or
 products.  The company's financial performance and the forward-looking
 statements contained herein are further qualified by a detailed discussion of
 associated risks set forth in the documents filed by the company with the
 Securities and Exchange Commission, including the company's most recent Form
 10-K and Form 10-Q.  The forward-looking statements set forth the company's
 beliefs as of the date of this release, and the company assumes no duty to
 update the forward-looking statements contained in this release to reflect any
 change.
 
     Nu Skin Enterprises, Nu Skin, Pharmanex and Big Planet are registered
 trademarks in the United States and/or other countries.  Other product and
 company names herein may be trademarks of their respective owners.
 
 
                             Nu Skin Enterprises, Inc.
                         Consolidated Statements of Income
                For the First Quarters Ended March 31, 2001 and 2000
                      (in thousands, except per share amounts)
 
                                                      2001            2000
     Revenue
      North Asia                                     $129,959       $140,373
      Southeast Asia                                   30,785         30,411
      North America                                    43,440         38,354
      Other                                             6,075          4,487
     Total revenue                                    210,259        213,625
 
     Cost of sales                                     42,515         34,291
     Gross margin                                     167,744        179,334
 
     Operating expenses
      Distributor incentives                           81,834         82,795
      Selling, general and administrative              72,898         74,997
     Total operating expenses                         154,732        157,792
 
     Operating income                                  13,012         21,542
 
     Other income (expense), net                        6,959          1,689
     Income before provision for income taxes          19,971         23,231
     Provision for income taxes                         7,389          8,363
     Net income                                       $12,582        $14,868
 
     Net income per share
      Basic                                            $ 0.15         $ 0.17
      Diluted                                          $ 0.15         $ 0.17
 
     Weighted average number of shares outstanding
      Basic                                            84,092         86,542
      Diluted                                          84,934         87,196
 
 
                             Nu Skin Enterprises, Inc.
                            Consolidated Balance Sheets
                                   (in thousands)
 
                                                    March 31,    December 31,
                                                      2001            2000
     ASSETS
     Current assets
      Cash and cash equivalents                       $51,537         $63,996
      Accounts receivable                              20,793          18,191
      Related parties receivable                       12,668          13,176
      Inventories, net                                 79,164          82,015
      Prepaid expenses and other                       40,016          44,513
                                                      204,178         221,891
 
     Property and equipment, net                       61,614          60,562
     Other assets, net                                301,310         308,350
       Total assets                                 $ 567,102       $ 590,803
 
     LIABILITIES AND STOCKHOLDERS' EQUITY
     Current liabilities
      Accounts payable                                $14,816          $15,83
      Accrued expenses                                 60,541          74,199
      Related parties payable                           8,062           9,020
                                                       83,419          99,056
 
     Long-term debt                                    76,908          84,884
     Other liabilities                                 41,239          40,130
      Total liabilities                               201,566         224,070
 
     Stockholders' equity
      Class A common stock                                 32              31
      Class B common stock                                 52              54
      Additional paid-in capital                      100,453         106,284
      Accumulated other comprehensive income          (49,904)        (45,347)
      Retained earnings                               315,071         306,458
      Deferred compensation                              (168)           (747)
                                                      365,536         366,733
       Total liabilities and stockholders' equity    $567,102        $590,803
 
 
                             Nu Skin Enterprises, Inc.
                            Distributor Growth by Market
 
                  As of March 31, 2001   As of March 31, 2000     % Increase
                     Active   Executive   Active  Executive  Active  Executive
     North Asia      287,000    14,994    291,000     14,830   (1.4%)    1.1%
     Southeast Asia  104,000     3,110     98,000      3,234    6.1%    (3.8%)
     North America    52,000     2,506     56,000      2,972   (7.1%)  (15.7%)
     Other            23,000       839     17,000        472   35.3%    77.8%
 
     Total           466,000    21,449    462,000     21,508    0.9%    (0.3%)
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X44624869
 
 

SOURCE Nu Skin Enterprises, Inc.
    PROVO, Utah, April 26 /PRNewswire/ -- Nu Skin Enterprises, Inc.
 (NYSE:   NUS) today reported financial results for the first quarter ended March
 31, 2001.
 
                               Financial Results
     "Global revenue was up 6 percent year-over-year in constant currency, and
 we were pleased to realize overall results that were within our expectations,"
 said Steven J. Lund, president and chief executive officer, commenting on
 first quarter results.  "Weak foreign currencies negatively impacted our
 reported revenue, however, offsetting significant product sales from a global
 distributor convention held in February."
     For the first quarter, the company's reported revenue was $210.3 million
 compared to $213.6 million for the first quarter of 2000.  Net income was
 $12.6 million and earnings per share were $0.15 compared to $14.9 million and
 $0.17 per share for the same prior-year period.
 
                                Regional Results
     North Asia.  Revenue in the North Asia region was up 2 percent year-over-
 year on a constant currency basis.  However, due to negative foreign currency
 impact, revenue in the region declined 7 percent in U.S. dollars.  In Japan,
 local currency revenue remained level with the prior year, a positive showing
 given a convention was held in Japan during the prior year period.  In South
 Korea, revenue growth continued, up nearly 60 percent in local currency.
     Southeast Asia.  In constant currency, revenue in the Southeast Asia
 region rose 4 percent over a year ago, or 1 percent on a reported U.S. dollar
 basis, largely from revenue in Singapore, where operating results continue to
 exceed expectations.  The company's success in Singapore offset a 16 percent
 year-over-year decline in Taiwan in local currency.  Taiwan continues to
 suffer from distributor focus on stronger markets in the region and from a
 competitive local business environment.
     North America.  Revenue in the North America region was up 13 percent over
 the first quarter of 2000, with all three divisions benefiting from the
 successful February convention, which generated $5 million in incremental
 revenue.  Revenue in North America was also positively impacted by
 $5.7 million from a new business development venture that is included in Big
 Planet's results.  Without the impact of this additional revenue and
 incremental convention sales, revenue in North America would have been down
 13 percent year-over-year, but essentially level on a sequential basis.
     Other Markets.  All other markets experienced year-over-year gains, in
 local currency, up a collective 35 percent from first quarter 2000 results.
 European markets showed an increase of 52 percent in local currency,
 42 percent in U.S. dollars.  The Scandinavian countries, in particular, showed
 increases in both distributor leadership and revenue.
 
                               Divisional Reports
     Nu Skin Division.  Revenue from the Nu Skin division during the first
 quarter was down 2 percent year-over-year in constant currency terms, and down
 10 percent on a reported U.S. dollar basis to $100.1 million.  Two of the
 products introduced at the convention, the Galvanic Spa System(TM) and Tru
 Face(TM) Line Corrector, quickly became two of the division's top selling
 products in the U.S.  These and other new products will be rolled out globally
 during 2001.
     Pharmanex.  First quarter revenue from Pharmanex was up 12 percent in
 constant currency terms, and up 3 percent in U.S. dollars to $93.4 million.
 Pharmanex's personalized distributor web site program continues to drive
 growth in Japan, with some 26,000 sites now in operation.  In addition, the
 distributor automatic ordering program, launched in 2000 in Japan, now
 accounts for 30 percent of global division revenue, providing a more stable,
 recurring revenue stream.  During the February convention, Pharmanex
 introduced both Body Design(TM), a weight management system, as well as its
 reformulated anti-aging LifePak(TM) line of products.
     In early April, a U.S. Federal judge ruled that Cholestin, Pharmanex's
 primary cholesterol product, could no longer be marketed in the U.S. as a
 dietary supplement.  A more comprehensive cardiovascular product, Cardio
 Formula(TM), which was introduced at convention, is now being sold in the U.S.
 International sales of Cholestin are not expected to be affected by the U.S.
 ruling.
 
     Big Planet.  Big Planet's core global revenue was $11.1 million for the
 quarter, up 18 percent from a year ago, including $2.6 million of revenue from
 international markets.  With the inclusion of $5.7 million of new business
 development revenue in the quarter, which previously was not included in Big
 Planet's results, global revenue was $16.8 million.  Big Planet's U.S. revenue
 declined 10 percent from the previous year, due largely to the company's
 decision to discontinue unprofitable programs and to focus on improving
 operating margins.  For example, during the quarter, Big Planet entered into a
 relationship with Planet Electric to distribute products incorporating
 innovative battery technology.  The cash investment in Big Planet was
 $4.5 million in the quarter, and is expected to be less than $3 million in the
 second quarter.
 
                            Operational Performance
     Gross margins were lower in the first quarter, due primarily to the impact
 of weaker foreign currencies and from an increase in lower margin Big Planet
 revenue.  Selling, general and administrative expenses were lower than
 projected, due to tightened cost controls, as well as a weakened Japanese Yen.
 SG&A expenses for the quarter also included the cost of the global convention.
 With a renewed focus on cost-containment, as well as the projected impact of a
 stronger dollar, quarterly SG&A expenses are expected to be lower throughout
 the remainder of 2001.  While operating income was negatively affected by
 foreign currencies, significant hedging gains as a result of the stronger U.S.
 dollar helped to offset the currency impact.  As a result, net income and
 earnings per share were in line with the company's expectations for the
 quarter.
 
                                    Outlook
     "Overall," Mr. Lund noted, "we are optimistic about the outlook for local
 currency revenue growth in most of our international markets.  But weak
 foreign currencies, particularly the Japanese Yen, will impact revenue and
 earnings per share for the year.  At a forecasted exchange rate of 125 Yen to
 the U.S. dollar, the outlook for revenue in 2001 is between $840 and
 $870 million, with earnings per share of $0.58 to $0.62.  We also expect
 reported revenue and earnings per share in the second quarter to be relatively
 level with first quarter results."
     Mr. Lund emphasized that the company's priorities during 2001 will be to
 accomplish five major goals, which are:
 
     --  to grow the U.S. business;
     --  to refine the company's divisional strategy;
     --  to increase distributor productivity through Internet and automatic
         delivery type programs;
     --  to further tighten cost controls consistent with projected revenue
         levels; and,
     --  to globalize new product offerings.
 
     "These priorities reflect our commitment to constantly adapt to meet the
 changing business environment in which we operate.  While always supporting
 the need for stability in our business, we will staunchly adhere to the tenet
 that our business success comes from adjusting, as necessary, both our goals
 and the tactics necessary to reach them," he concluded.
 
     The Company
     Nu Skin Enterprises, Inc. is one of the largest direct selling companies
 in the world.  The company's products are sold in more than 30 countries
 throughout the Americas, Europe and the Asia Pacific region.  Nu Skin
 Enterprises is traded on the New York Stock Exchange under the symbol "NUS."
     Nu Skin Enterprises offers three distinct business opportunities
 specializing in consumer products and services sold through direct sales.  Nu
 Skin markets premium quality face, body and hair care products.  Pharmanex is
 a science-based developer and marketer of nutritional supplements.  Big Planet
 concentrates on the marketing and distribution of technology-based products
 and services.
     Nu Skin Enterprises news releases are available online at
 www.nuskinenterprises.com or through the Company News On-Call fax service. For
 a menu of Nu Skin Enterprises news or to retrieve a specific release, call
 800-758-5804, extension 119638.
 
     Please note:  This press release contains forward-looking statements
 within the meaning of Section 21E of the Securities Exchange Act of 1934 that
 represent the company's current expectations and beliefs, including, among
 other things: (i) expectations that the cash investment in Big Planet will be
 less than $3 million in the 2nd quarter, (ii) the belief that selling, general
 and administrative expenses will be lower for the remainder of the year, (iii)
 the forecast that revenue for 2001 will be between $840 and $870 million and
 earnings per share will be $0.58 to $0.62, and (iv) the belief that revenue
 and earnings for the second quarter will be relatively level with the first
 quarter.  The company wishes to caution and advise readers that these
 statements are based on assumptions which may not materialize, including
 assumptions that the Japanese Yen will remain at current levels and that the
 company's initiatives in Japan will continue to have a positive impact on
 revenue.  The forward-looking statements and related assumptions involve risks
 and uncertainties that could cause actual results and outcomes to differ
 materially from any forward-looking statements or views expressed herein.
 These risks and uncertainties include, but are not limited to: (a) adverse
 changes in currency exchange rates, particularly the Japanese Yen; (b)
 continued or increased economic problems in the company's markets,
 particularly the United States and Japan, that have negatively impacted
 consumer spending in those markets; (c) uncertainty concerning the long-term
 effects of recent initiatives and the risk that the recent stabilization of
 operations in Japan may not be sustained or be indicative of future operating
 results; (d) uncertainties regarding the degree to which the new products
 launched at convention will gain market acceptance and generate interest among
 distributors and consumers in global markets; (e) any inability of the company
 to successfully develop and implement strategic initiatives that will generate
 new and sustained growth in Taiwan and the United States; (f) continued
 competitive pressures in the company's markets; and, (g) regulatory risks
 associated with the company's business and product offerings, including
 possible restrictions on or challenges to the company's marketing practices or
 products.  The company's financial performance and the forward-looking
 statements contained herein are further qualified by a detailed discussion of
 associated risks set forth in the documents filed by the company with the
 Securities and Exchange Commission, including the company's most recent Form
 10-K and Form 10-Q.  The forward-looking statements set forth the company's
 beliefs as of the date of this release, and the company assumes no duty to
 update the forward-looking statements contained in this release to reflect any
 change.
 
     Nu Skin Enterprises, Nu Skin, Pharmanex and Big Planet are registered
 trademarks in the United States and/or other countries.  Other product and
 company names herein may be trademarks of their respective owners.
 
 
                             Nu Skin Enterprises, Inc.
                         Consolidated Statements of Income
                For the First Quarters Ended March 31, 2001 and 2000
                      (in thousands, except per share amounts)
 
                                                      2001            2000
     Revenue
      North Asia                                     $129,959       $140,373
      Southeast Asia                                   30,785         30,411
      North America                                    43,440         38,354
      Other                                             6,075          4,487
     Total revenue                                    210,259        213,625
 
     Cost of sales                                     42,515         34,291
     Gross margin                                     167,744        179,334
 
     Operating expenses
      Distributor incentives                           81,834         82,795
      Selling, general and administrative              72,898         74,997
     Total operating expenses                         154,732        157,792
 
     Operating income                                  13,012         21,542
 
     Other income (expense), net                        6,959          1,689
     Income before provision for income taxes          19,971         23,231
     Provision for income taxes                         7,389          8,363
     Net income                                       $12,582        $14,868
 
     Net income per share
      Basic                                            $ 0.15         $ 0.17
      Diluted                                          $ 0.15         $ 0.17
 
     Weighted average number of shares outstanding
      Basic                                            84,092         86,542
      Diluted                                          84,934         87,196
 
 
                             Nu Skin Enterprises, Inc.
                            Consolidated Balance Sheets
                                   (in thousands)
 
                                                    March 31,    December 31,
                                                      2001            2000
     ASSETS
     Current assets
      Cash and cash equivalents                       $51,537         $63,996
      Accounts receivable                              20,793          18,191
      Related parties receivable                       12,668          13,176
      Inventories, net                                 79,164          82,015
      Prepaid expenses and other                       40,016          44,513
                                                      204,178         221,891
 
     Property and equipment, net                       61,614          60,562
     Other assets, net                                301,310         308,350
       Total assets                                 $ 567,102       $ 590,803
 
     LIABILITIES AND STOCKHOLDERS' EQUITY
     Current liabilities
      Accounts payable                                $14,816          $15,83
      Accrued expenses                                 60,541          74,199
      Related parties payable                           8,062           9,020
                                                       83,419          99,056
 
     Long-term debt                                    76,908          84,884
     Other liabilities                                 41,239          40,130
      Total liabilities                               201,566         224,070
 
     Stockholders' equity
      Class A common stock                                 32              31
      Class B common stock                                 52              54
      Additional paid-in capital                      100,453         106,284
      Accumulated other comprehensive income          (49,904)        (45,347)
      Retained earnings                               315,071         306,458
      Deferred compensation                              (168)           (747)
                                                      365,536         366,733
       Total liabilities and stockholders' equity    $567,102        $590,803
 
 
                             Nu Skin Enterprises, Inc.
                            Distributor Growth by Market
 
                  As of March 31, 2001   As of March 31, 2000     % Increase
                     Active   Executive   Active  Executive  Active  Executive
     North Asia      287,000    14,994    291,000     14,830   (1.4%)    1.1%
     Southeast Asia  104,000     3,110     98,000      3,234    6.1%    (3.8%)
     North America    52,000     2,506     56,000      2,972   (7.1%)  (15.7%)
     Other            23,000       839     17,000        472   35.3%    77.8%
 
     Total           466,000    21,449    462,000     21,508    0.9%    (0.3%)
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X44624869
 
 SOURCE  Nu Skin Enterprises, Inc.